Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 257

Results For "CRE"

4459 News Found

CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells
News | April 12, 2023

CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells

CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells


Calibre Chemicals takes over R&D activities of Tina Life Sciences
News | April 11, 2023

Calibre Chemicals takes over R&D activities of Tina Life Sciences

Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.


Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development
News | April 11, 2023

Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development

To enable company to be future-ready by tapping potential in CDMO space


Need of the hour is Indian Research, Data and Solution to Indian problems: Dr Jitendra Singh
News | April 10, 2023

Need of the hour is Indian Research, Data and Solution to Indian problems: Dr Jitendra Singh

He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir


AIIA hosts walkthrough for Working Group of C20 on Integrated Holistic Health
News | April 10, 2023

AIIA hosts walkthrough for Working Group of C20 on Integrated Holistic Health

MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda


Newly patented bone marrow biopsy device to bolster bone cancer treatment in India, says GlobalData
News | April 10, 2023

Newly patented bone marrow biopsy device to bolster bone cancer treatment in India, says GlobalData

It provides doctors with three indicators: identification of the bone, confirmation of device insertion into the bone, and notification in case of perforation through the opposite end of the bone


Cognizant, Microsoft collaborate to bring cloud-based solutions to the healthcare market
Digitisation | April 08, 2023

Cognizant, Microsoft collaborate to bring cloud-based solutions to the healthcare market

Microsoft Cloud for Healthcare and Cognizant’s TriZetto healthcare products aim to enhance transparency for consumers and increase interoperability for providers and payers


Tillotts Pharma announces the launch of Octasa 1600 mg Tablets in Canada
News | April 08, 2023

Tillotts Pharma announces the launch of Octasa 1600 mg Tablets in Canada

The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.


Inflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, says GlobalData
News | April 08, 2023

Inflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, says GlobalData

FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop


Zydus receives final approval from the USFDA for Acetazolamide Tablets
Drug Approval | April 07, 2023

Zydus receives final approval from the USFDA for Acetazolamide Tablets

Acetazolamide is used to treat glaucoma